Effects of Selenium Supplementation on Gene Expression Levels of Inflammatory Cytokines and Vascular Endothelial Growth Factor in Patients with Gestational Diabetes

Biological Trace Element Research

Volumn 181, Issue 2, 2018, Pages 199-206

  Jamilian, Mehri ^a   Samimi, Mansooreh ^b   Afshar Ebrahimi, Faraneh ^b   Aghadavod, Esmat ^b   Mohammadbeigi, Robabeh ^c   Rahimi, Maryam ^c   Asemi, Zatollah ^b  

^a ARAK UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KASHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Gene expression; Gestational diabetes; Inflammation; Selenium

Indexed keywords

PLACEBO; SELENIUM; CYTOKINE; VASCULOTROPIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IL 1BETA GENE; IL 8 GENE; INFLAMMATION; LYMPHOCYTE; PREGNANCY DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPPLEMENTATION; TGF BETA GENE; TNF ALPHA GENE; VEGF GENE; ADOLESCENT; BLOOD; DIETARY SUPPLEMENT; GENETICS; METABOLISM; PREGNANCY; REAL TIME POLYMERASE CHAIN REACTION; YOUNG ADULT;

ADOLESCENT; ADULT; CYTOKINES; DIABETES, GESTATIONAL; DIETARY SUPPLEMENTS; FEMALE; HUMANS; INFLAMMATION; PREGNANCY; REAL-TIME POLYMERASE CHAIN REACTION; SELENIUM; VASCULAR ENDOTHELIAL GROWTH FACTORS; YOUNG ADULT;

EID: 85019564067     PISSN: 01634984     EISSN: 15590720     Source Type: Journal    
DOI: 10.1007/s12011-017-1045-8     Document Type: Article

References (53)

1. Mishra S, Rao CR, Shetty A (2016) Trends in the diagnosis of gestational diabetes mellitus. Scientifica (Cairo) 2016:5489015
2. Durnwald C (2015) Gestational diabetes: linking epidemiology, excessive gestational weight gain, adverse pregnancy outcomes, and future metabolic syndrome. Semin Perinatol 39:254–258
3. Jafari-Shobeiri M, Ghojazadeh M, Azami-Aghdash S et al (2015) Prevalence and risk factors of gestational diabetes in Iran: a systematic review and meta-analysis. Iran J Public Health 44:1036–1044
4. Fasshauer M, Bluher M, Stumvoll M (2014) Adipokines in gestational diabetes. Lancet Diabetes Endocrinol 2:488–499
5. Madazli R, Tuten A, Calay Z, Uzun H, Uludag S, Ocak V (2008) The incidence of placental abnormalities, maternal and cord plasma malondialdehyde and vascular endothelial growth factor levels in women with gestational diabetes mellitus and nondiabetic controls. Gynecol Obstet Investig 65:227–232
6. Meng Q, Shao L, Luo X et al (2016) Expressions of VEGF-A and VEGFR-2 in placentae from GDM pregnancies. Reprod Biol Endocrinol 14:61
7. Naziroglu M (2009) Role of selenium on calcium signaling and oxidative stress-induced molecular pathways in epilepsy. Neurochem Res 34:2181–2191
8. Lee SR, Bar-Noy S, Kwon J, Levine RL, Stadtman TC, Rhee SG (2000) Mammalian thioredoxin reductase: oxidation of the C-terminal cysteine/selenocysteine active site forms a thioselenide, and replacement of selenium with sulfur markedly reduces catalytic activity. Proc Natl Acad Sci U S A 97:2521–2526
9. Christensen MJ, Pusey NW (1994) Binding of nuclear proteins to transcription regulatory elements in selenium deficiency. Biochim Biophys Acta 1225:338–341
10. Asemi Z, Jamilian M, Mesdaghinia E, Esmaillzadeh A (2015) Effects of selenium supplementation on glucose homeostasis, inflammation, and oxidative stress in gestational diabetes: randomized, double-blind, placebo-controlled trial. Nutrition 31:1235–1242
11. Kahya MC, Naziroglu M, Cig B (2015) Melatonin and selenium reduce plasma cytokine and brain oxidative stress levels in diabetic rats. Brain Inj 29:1490–1496
12. Daeian N, Radfar M, Jahangard-Rafsanjani Z, Hadjibabaie M, Ghavamzadeh A (2014) Selenium supplementation in patients undergoing hematopoietic stem cell transplantation: effects on pro-inflammatory cytokines levels. Daru 22:51
13. Vunta H, Belda BJ, Arner RJ, Channa Reddy C, Vanden Heuvel JP, Sandeep Prabhu K (2008) Selenium attenuates pro-inflammatory gene expression in macrophages. Mol Nutr Food Res 52:1316–1323
14. Vunta H, Davis F, Palempalli UD et al (2007) The anti-inflammatory effects of selenium are mediated through 15-deoxy-Delta12,14-prostaglandin J2 in macrophages. J Biol Chem 282:17964–17973
15. American Diabetes Association (2014) Diagnosis and classification of diabetes mellitus. Diabetes Care 37(Suppl 1):S81–S90
16. Ainsworth BE, Haskell WL, Whitt MC et al (2000) Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 32:S498–S504
17. Harada A, Sekido N, Akahoshi T, Wada T, Mukaida N, Matsushima K (1994) Essential involvement of interleukin-8 (IL-8) in acute inflammation. J Leukoc Biol 56:559–564
18. Vlahopoulos S, Boldogh I, Casola A, Brasier AR (1999) Nuclear factor-kappaB-dependent induction of interleukin-8 gene expression by tumor necrosis factor alpha: evidence for an antioxidant sensitive activating pathway distinct from nuclear translocation. Blood 94:1878–1889
19. Gmelig-Meyling F, Waldmann TA (1980) Separation of human blood monocytes and lymphocytes on a continuous Percoll gradient. J Immunol Methods 33:1–9
20. Bi CL, Wang H, Wang YJ et al (2016) Selenium inhibits Staphylococcus Aureus-induced inflammation by suppressing the activation of the NF-kappaB and MAPK signalling pathways in RAW264.7 macrophages. Eur J Pharmacol 780:159–165
21. Liu Y, Liu Q, Ye G et al (2015) Protective effects of selenium-enriched probiotics on carbon tetrachloride-induced liver fibrosis in rats. J Agric Food Chem 63:242–249
22. Algotar AM, Behnejad R, Singh P, Thompson PA, Hsu CH, Stratton SP (2015) Effect of selenium supplementation on proteomic serum biomarkers in elderly men. J Frailty Aging 4:107–110
23. Bahmani F, Kia M, Soleimani A, Mohammadi AA, Asemi Z (2016) The effects of selenium supplementation on biomarkers of inflammation and oxidative stress in patients with diabetic nephropathy: a randomised, double-blind, placebo-controlled trial. Br J Nutr 116:1222–1228
24. Jones HN, Jansson T, Powell TL (2009) IL-6 stimulates system A amino acid transporter activity in trophoblast cells through STAT3 and increased expression of SNAT2. Am J Physiol Cell Physiol 297:C1228–C1235
25. Goenner S, Cosson C, Boutron A, Legrand A, Moatti N (1997) Interleukin-1 beta and interleukin-6 stimulate 2-methylaminoisobutyric acid uptake in HepG2 cells. Int J Biochem Cell Biol 29:667–674
26. Jansson N, Rosario FJ, Gaccioli F et al (2013) Activation of placental mTOR signaling and amino acid transporters in obese women giving birth to large babies. J Clin Endocrinol Metab 98:105–113
27. Jansson T, Ylven K, Wennergren M, Powell TL (2002) Glucose transport and system A activity in syncytiotrophoblast microvillous and basal plasma membranes in intrauterine growth restriction. Placenta 23:392–399
28. Kirwan JP, Hauguel-De Mouzon S, Lepercq J et al (2002) TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes 51:2207–2213
29. Lopez-Tinoco C, Roca M, Fernandez-Deudero A et al (2012) Cytokine profile, metabolic syndrome and cardiovascular disease risk in women with late-onset gestational diabetes mellitus. Cytokine 58:14–19
30. Coughlan MT, Oliva K, Georgiou HM, Permezel JM, Rice GE (2001) Glucose-induced release of tumour necrosis factor-alpha from human placental and adipose tissues in gestational diabetes mellitus. Diabet Med 18:921–927
31. Bartha JL, Gonzalez-Bugatto F, Fernandez-Macias R, Gonzalez-Gonzalez NL, Comino-Delgado R, Hervias-Vivancos B (2008) Metabolic syndrome in normal and complicated pregnancies. Eur J Obstet Gynecol Reprod Biol 137:178–184
32. Xu Y, Shen S, Sun L, Yang H, Jin B, Cao X (2014) Metabolic syndrome risk after gestational diabetes: a systematic review and meta-analysis. PLoS One 9:e87863
33. Pantham P, Aye IL, Powell TL (2015) Inflammation in maternal obesity and gestational diabetes mellitus. Placenta 36:709–715
34. Lager S, Jansson N, Olsson AL, Wennergren M, Jansson T, Powell TL (2011) Effect of IL-6 and TNF-alpha on fatty acid uptake in cultured human primary trophoblast cells. Placenta 32:121–127
35. Ram M, Singh V, Kumawat S et al (2015) Deferoxamine modulates cytokines and growth factors to accelerate cutaneous wound healing in diabetic rats. Eur J Pharmacol 764:9–21
36. Ybarra J, Pou JM, Romeo JH, Merce J, Jurado J (2010) Transforming growth factor beta 1 as a biomarker of diabetic peripheral neuropathy: cross-sectional study. J Diabetes Complicat 24:306–312
37. Shankland SJ, Scholey JW, Ly H, Thai K (1994) Expression of transforming growth factor-beta 1 during diabetic renal hypertrophy. Kidney Int 46:430–442
38. Blobe GC, Schiemann WP, Lodish HF (2000) Role of transforming growth factor beta in human disease. N Engl J Med 342:1350–1358
39. Samad F, Pandey M, Loskutoff DJ (1998) Tissue factor gene expression in the adipose tissues of obese mice. Proc Natl Acad Sci U S A 95:7591–7596
40. Ghosh J, Murphy MO, Turner N et al (2005) The role of transforming growth factor beta1 in the vascular system. Cardiovasc Pathol 14:28–36
41. Kurihara H, Yoshizumi M, Sugiyama T et al (1989) Transforming growth factor-beta stimulates the expression of endothelin mRNA by vascular endothelial cells. Biochem Biophys Res Commun 159:1435–1440
42. Stewart DJ, Levy RD, Cernacek P, Langleben D (1991) Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease? Ann Intern Med 114:464–469
43. Border WA, Noble NA (1998) Interactions of transforming growth factor-beta and angiotensin II in renal fibrosis. Hypertension 31:181–188
44. Zamamiri-Davis F, Lu Y, Thompson JT et al (2002) Nuclear factor-kappaB mediates over-expression of cyclooxygenase-2 during activation of RAW 264.7 macrophages in selenium deficiency. Free Radic Biol Med 32:890–897
45. Li Y, Ran W, Zhang J et al (2016) Circulating milk fat globule-epidermal growth factor 8 levels are increased in pregnancy and gestational diabetes mellitus. J Diabetes Investig doi. doi:10.1111/jdi.12616
46. Lappas M, Permezel M, Rice GE (2004) Release of proinflammatory cytokines and 8-isoprostane from placenta, adipose tissue, and skeletal muscle from normal pregnant women and women with gestational diabetes mellitus. J Clin Endocrinol Metab 89:5627–5633
47. Christian LM, Porter K (2014) Longitudinal changes in serum proinflammatory markers across pregnancy and postpartum: effects of maternal body mass index. Cytokine 70:134–140
48. Bajpai S, Mishra M, Kumar H et al (2011) Effect of selenium on connexin expression, angiogenesis, and antioxidant status in diabetic wound healing. Biol Trace Elem Res 144:327–338
49. Blass SC, Goost H, Tolba RH et al (2012) Time to wound closure in trauma patients with disorders in wound healing is shortened by supplements containing antioxidant micronutrients and glutamine: a PRCT. Clin Nutr 31:469–475
50. Chang SC, Vivian Yang WC (2013) Hyperglycemia induces altered expressions of angiogenesis associated molecules in the trophoblast. Evid Based Complement Alternat Med 2013:457971
51. Ferrara N, Gerber HP, LeCouter J (2003) The biology of VEGF and its receptors. Nat Med 9:669–676
52. Charnock-Jones DS, Kaufmann P, Mayhew TM (2004) Aspects of human fetoplacental vasculogenesis and angiogenesis. I Molecular regulation Placenta 25:103–113
53. Demir R, Kayisli UA, Seval Y et al (2004) Sequential expression of VEGF and its receptors in human placental villi during very early pregnancy: differences between placental vasculogenesis and angiogenesis. Placenta 25:560–572